GoKawiilNeuroAge Therapeutics CEO launches 'Younger' contest to compare biological aging clocks
Neuroscientist Christin Glorioso, founder of NeuroAge Therapeutics, has created a competition called Younger that pits participants against each other based on measurements of biological age. Entrants will submit samples to services such as TruDiagnostic, which uses epigenetic markers to estimate overall biological age, pace of aging, and the ages of 11 individual organ systems. Glorioso says the contest aims to educate the public about aging clocks and to build what she calls the world's most comprehensive dataset on them.
GoKawiil's interpretation of the reporting above, not reported fact.
Aging clocks are widely used in research but remain contested as tools for assessing an individual's biological age, since scientists still don't fully understand what each clock actually measures. By gathering data from many competitors using multiple clocks, the contest could help researchers compare how different methods align or diverge, though this is Glorioso's stated hope rather than a proven outcome. The effort also highlights a growing commercial market offering biological age testing despite acknowledged scientific limitations.
- Christin Glorioso, CEO of NeuroAge Therapeutics, organized the Younger aging-clock competition.
- Over 100 aging clocks exist, measuring different biological signals like DNA chemical marks, proteins, or lipids.
- The contest uses services like TruDiagnostic to estimate biological age, aging pace, and organ-specific aging.
Source: technologyreview.com — Jessica Hamzelou, 2026-10-02
Published there as: “A new contest pits competitors against each other in a race to biological youth”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.